# High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)

> **NCT07192458** · PHASE2 · RECRUITING · sponsor: **Vanderbilt University Medical Center** · enrollment: 60 (estimated)

## Conditions studied

- Immunization; Infection|Transplantation Infection|Influenza
- Influenza

## Interventions

- **BIOLOGICAL:** Fluzone High Dose Inactivated Influenza Vaccine
- **BIOLOGICAL:** Fluzone Standard Dose Inactivated Influenza Vaccine

## Key facts

- **NCT ID:** NCT07192458
- **Lead sponsor:** Vanderbilt University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-09-17
- **Primary completion:** 2028-12
- **Final completion:** 2029-12
- **Target enrollment:** 60 (ESTIMATED)
- **Last updated:** 2025-10-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07192458

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07192458, "High vs. Standard Dose Influenza Vaccines in Lung Transplant (Repeater)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT07192458. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*